Report copyright - Effects of reducing blood pressure on cardiovascular ... DCRP SGLT2 re… · Empagliflozin, a sodium-glucose cotransporter type 2 (SGLT2) inhibitor, has shown a remarkable reduction
Please pass captcha verification before submit form